232 related articles for article (PubMed ID: 2195283)
21. Molecular epidemiology of malaria in cameroon. IX. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children.
Basco LK; Ndounga M; Keundjian A; Ringwald P
Am J Trop Med Hyg; 2002 Feb; 66(2):117-23. PubMed ID: 12135279
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine resistant Plasmodium falciparum malaria in East New Britain, Papua New Guinea.
Tulloch A
P N G Med J; 1980 Sep; 23(3):117-25. PubMed ID: 7008425
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
Fowler VG; Lemnge M; Irare SG; Malecela E; Mhina J; Mtui S; Mashaka M; Mtoi R
J Trop Med Hyg; 1993 Dec; 96(6):337-45. PubMed ID: 8254710
[TBL] [Abstract][Full Text] [Related]
24. Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon.
Louis JP; Hengy C; Louis FJ; Gazin P; Jambou R; Gardon J; Fadat G; Trebucq A
Trop Med Parasitol; 1992 Jun; 43(2):118-20. PubMed ID: 1519023
[TBL] [Abstract][Full Text] [Related]
25. [Uncomplicated attack of malaria in an area with high resistance to chloroquine. I. Evaluation of a short treatment with quinine].
Jambou R; Abissegue B; Gelas H; Ghipponi PM; Farinotti R; Le Bras J; Hengy C
Bull Soc Pathol Exot; 1990; 83(1):46-52. PubMed ID: 2190704
[TBL] [Abstract][Full Text] [Related]
26. [Parasitological and clinical response to amodiaquine versus chloroquine in the treatment of Plasmodium falciparum malaria in children in an endemic area].
Penali LK; Assi-Coulibaly L; Kaptué B; Konan D; Ehouman A
Bull Soc Pathol Exot; 1994; 87(4):244-7. PubMed ID: 7866044
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire].
Adjetey TA; Affoumou GB; Loukou DD; Nebavi NG; Barro-Kiki P; Menan EI; Yavo W; Kone M
Bull Soc Pathol Exot; 2005 Sep; 98(3):193-6. PubMed ID: 16267959
[TBL] [Abstract][Full Text] [Related]
28. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
[TBL] [Abstract][Full Text] [Related]
29. [Surveillance of the in vivo sensitivity of Plasmodium falciparum to antimalarial agents: the results of initial tests of the OCEAC Malaria Network].
Chambon R; Lemardeley P; Boudin C; Ringwald P; Chandenier J
Med Trop (Mars); 1997; 57(4):357-60. PubMed ID: 9612776
[TBL] [Abstract][Full Text] [Related]
30. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK
East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656
[TBL] [Abstract][Full Text] [Related]
31. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
[TBL] [Abstract][Full Text] [Related]
32. Application of a simplified in-vivo test system for determining chloroquine resistance in Plasmodium falciparum.
Prasad RN; Prasad H; Virk KJ; Sharma VP
Bull World Health Organ; 1990; 68(6):755-8. PubMed ID: 2073712
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G
Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911
[TBL] [Abstract][Full Text] [Related]
34. In vitro responses of P. falciparum parasites to chloroquine, amodiaquine and quinine in two ecological zones in Ghana.
Afari EA; Akanmori BD; Nakano T; Ofori-Adjei D
Cent Afr J Med; 1993 Jul; 39(7):136-40. PubMed ID: 8205605
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of chloroquine and amodiaquine in Plasmodium falciparum strain of north-eastern India.
Pandya AP; Barkakaty BN; Narasimham MV
J Commun Dis; 1994 Jun; 26(2):61-7. PubMed ID: 7989677
[TBL] [Abstract][Full Text] [Related]
36. Serial studies on the evolution of drug resistance in malaria in an area of east Africa: findings from 1979 up to 1986.
Draper CC; Hills M; Kilimali VA; Brubaker G
J Trop Med Hyg; 1988 Oct; 91(5):265-73. PubMed ID: 3054140
[TBL] [Abstract][Full Text] [Related]
37. [Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].
Le Bras J; Simon F; Ramanamirija JA; Calmel MB; Hatin I; Deloron P; Porte J; Marchais H; Clausse JL; Biaud JM
Bull Soc Pathol Exot Filiales; 1987; 80(3 Pt 2):477-89. PubMed ID: 3319258
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
[TBL] [Abstract][Full Text] [Related]
39. In-vivo sensitivity of Plasmodium falciparum to chloroquine in Zaria, Nigeria.
Midala TA; Lege-Oguntoye L; Werblinska B; Bhatt GC
J Trop Med Hyg; 1988 Feb; 91(1):9-11. PubMed ID: 3279222
[TBL] [Abstract][Full Text] [Related]
40. In-vivo resistance of Plasmodium falciparum to chloroquine and amodiaquine in south Cameroon and age-related efficacy of the drugs.
le Hesran JY; Boudin C; Cot M; Personne P; Chambon R; Foumane V; Verhave JP; de Vries C
Ann Trop Med Parasitol; 1997 Sep; 91(6):661-4. PubMed ID: 9425369
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
